Learning archive

Kevin O'Leary: 'Biden-Harris Regulations Held Back Energy, But Markets Now Celebrate Expansion'
  • November 18, 2024

Kevin O'Leary: 'Biden-Harris Regulations Held Back Energy, But Markets Now Celebrate Expansion'

Kevin O’Leary recently appeared on The Daniela Cambone Show, where he discussed the current state of the U.S. energy sector and broader market trends. O’Leary, known for his outspoken views on business and investment, shared his thoughts on how regulatory changes under the Biden-Harris administration have impacted the economy, particularly in energy and how markets are reacting now. Don't Miss: With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has sk

Read More
Why Is Penny Stock HCW Biologics Surging On Monday?
  • November 18, 2024

Why Is Penny Stock HCW Biologics Surging On Monday?

HCW Biologics Inc (NASDAQ:HCWB) stock is trading higher during Monday premarket with a strong session volume of 10.03 million versus an average volume of 48.02K, as per data from Benzinga Pro. HCW Biologics and WY Biotech Co., Ltd., a China-based company specializing in the early-stage development of recombinant protein drugs and gene/cell therapies, have entered into a worldwide exclusive license agreement. The agreement covers the development and commercialization of one of HCW Biologics’ prod

Read More
Revolut gets UK trading license, set to offer UK & EU stock trading
  • November 18, 2024

Revolut gets UK trading license, set to offer UK & EU stock trading

The company, which recently secured a $45 billion valuation making it one of Europe's most valuable fintechs, will now compete with companies such as Trading 212, Freetrade, Hargreaves Lansdown and AJ Bell in the UK trading market. Revolut, which currently has more than 650,000 UK trading customers, earlier operated as a partnership where it offered an investment service through its app and retail customers could buy and sell shares listed in the United States. The company received a UK banking licence in July with some restrictions, ending a three-year wait for the authorisation and removing regulatory uncertainty that had held back its ambitions in Britain.

Read More